An online talk on early phase drug development from a non-clinical setting to use in humans
The process to obtain regulatory approval for a new drug has several phases, irrespective of whether the drug is a new chemical or biological entity, a new formulation, or a generic "me-too” drug.
This lecture, delivered by Viktoria McDonald, director and owner of AlbaTox Consulting Ltd., will provide an introduction to the two early phases of preclinical and first-in-human trials.
The talk will last for 45 minutes, and will be followed by time for questions from the audience.
Cost and booking
This event is free to attend and open to all. Advance registration is essential and the Zoom link will be circulated to registered attendees in advance.
For booking or website queries, contact Harriet McAra at email@example.com
or on 020 3925 3445.
Continuing Professional Development (CPD)
This event has been approved by the Royal Society of Biology for the purposes of CPD
and can be counted as 3 CPD points